Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III

CONCLUSIONS: SABA over-prescription was reported in nearly 50% of patients prescribed SABA in addition to maintenance therapy, underscoring the need to align clinical practices with the latest evidence-based recommendations and educate physicians and patients on appropriate SABA use.PMID:38057957 | DOI:10.3904/kjim.2023.086
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Source Type: research